Longevity Bros
Home › Glossary › Sarcopenia
Glossary

Sarcopenia: age-related muscle loss, how it is diagnosed, and what reverses it

Sarcopenia is what ageing looks like when nobody intervenes: 3–8% of muscle lost per decade after 30, accelerating after 60, ending in the frailty that takes independence. It is also one of the most reversible conditions in this glossary.

Reviewed by the Longevity Bros team · Updated 1 October 2026

Before you read onResearch and educational information for adults, not medical advice. This entry explains one longevity term — what it means, why it matters and what the evidence says — and nothing here diagnoses, treats, cures or prevents any condition. Baseline labs come before anything, and your own physician has the final word. Longevity Bros offers coaching and written research protocols only — we do not sell, supply, source or ship any compound.

What it means

Sarcopenia is the progressive loss of skeletal-muscle mass, strength and function with age. It has had its own diagnostic code since 2016. The EWGSOP2 definition (2019) starts with low strength (grip under 27 kg in men, 16 kg in women), confirms it with low muscle mass (DEXA appendicular lean mass under 7.0 kg/m² in men, 5.5 in women), and grades severity by physical performance (gait speed under 0.8 m/s).

The drivers are anabolic resistance (older muscle needs more protein and more stimulus to respond), inactivity, low protein intake, falling hormones, chronic inflammation and the loss of motor neurons.

Why it matters for longevity

Muscle is the body's largest glucose sink, its protein reserve for illness, and the thing that prevents falls. Sarcopenia predicts hospitalisation, fractures, loss of independence and mortality, and it interacts with insulin resistance and inflammaging in both directions. It is the condition most of the muscle-related advice in longevity is trying to prevent.

What the evidence says

The cohort data are consistent: low muscle mass and strength predict mortality in older adults (meta-analysis of 21 studies, hazard ratio around 1.6–2.0 for the lowest category). The intervention data are among the strongest in the field: Fiatarone 1994 (NEJM) gave 100 nursing-home residents aged 72–98 ten weeks of resistance training and found strength gains of over 100% and improved gait and stair-climbing.

Protein matters alongside training: the PROT-AGE consensus recommends 1.0–1.2 g/kg/day for healthy older adults and 1.2–1.5 g/kg for those with sarcopenia, with 25–40 g per meal to overcome anabolic resistance. Creatine adds about 1.4 kg of lean mass to training in older adults.

How to measure or use it

Related

Frequently asked questions

At what age does sarcopenia start?

Muscle loss begins around 30 at 3–8% per decade; it accelerates after 60. Clinical sarcopenia is usually diagnosed after 65 but can appear earlier in the inactive.

Can sarcopenia be reversed?

Substantially, at any age: resistance training doubled strength in nonagenarians in the Fiatarone trial. Protein and creatine amplify the effect.

How much protein do older adults need?

1.2–1.6 g per kg of body weight per day, with 25–40 g per meal, to overcome anabolic resistance.

Your own protocol

Want this applied to your own numbers?

Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.

Build my protocol Book a 15-minute call